Novavax Plummets On 'Substantial Uncertainty' For Its Future
reported lighter-than-expected fourth-quarter sales of its Covid vaccine late Tuesday and NVAX stock crashed. During the December quarter, Novavax sales grew 61% to $357 million. But that lagged expectations for $383 million, according to FactSet. The company cited growth in sales of its Covid…
#nvax #novavax #nuvaxovid #pfe #seagensoars